James L. Foght

Oncolyze, Inc. is a private company developing a novel technology for cancer treatment. The company is based in New York, NY and was founded by Steven J. Evans and John H. Abeles. The company's lead drug candidate targets the cancer cell membrane and selectively kills cancer cells and cancer stem cells while sparing normal cells, potentially providing a highly effective treatment with little to no side effects. The initial therapeutic target is acute myeloid leukemia (AML), a cancer with a low five-year survival rate. Oncolyze's drug has been shown to destroy leukemic cancer stem cells, disrupting current medical treatment. Steven J. Evans has been the CEO since incorporation.

Kidd & Co. LLC (Kidd) is a private equity firm founded in 1976 by William J. Kidd. The firm is headquartered in Old Greenwich, Connecticut.

Vector Asset Management, Inc. is a venture capital firm based in Deerfield, Illinois

Part of UBS Group AG, Kidder Peabody & Co., Inc. /Non Retail Unit/ is a security brokers & dealers. The company is based in Staten Island, NY.

Pinnacle Biologics, Inc. specializes in revitalizing healthcare therapies by developing approaches to the global commercialization of products. It engages in assisting pharmaceutical and biotech companies in providing full portfolio of services aimed at the commercialization or continuation. The company was founded by Viren Grover, Guillermo A. Herrera and James R. Miller in 2007 and is headquartered in Chicago, IL.

African Wildlife Foundation, Inc. operates an international conservation organization focused on the African continent. The organization programs and conservation strategies are based on science and designed to protect both the wild lands and wildlife of Africa. The organization was founded in 1961 and is headquartered in Washington, DC.

Illinois Ventures LLC (Illinois Ventures) is a venture capital firm founded in 2000. The firm is headquartered in Champaign, Illinois.

PharmaIN Corp. develops affinity-based drug delivery solutions for biotech and pharmaceutical applications. It develops drug therapies using its proprietary, novel drug delivery platform called Protected Graft Co-polymer. The company was founded by Elijah M. Bolotin in 2000 and is headquartered in Bothell, WA.